Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
16.6M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
+96K
-
Total reported value, excl. options
-
$203M
-
Value change
-
+$2.51M
-
Put/Call ratio
-
0.03
-
Number of buys
-
71
-
Number of sells
-
-27
-
Price
-
$16.82
Significant Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) as of Q4 2024
128 filings reported holding RIGL - RIGEL PHARMACEUTICALS INC - Common Stock as of Q4 2024.
RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 16.6M outstanding shares and own 72.57% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.75M shares), MORGAN STANLEY (1.56M shares), ARMISTICE CAPITAL, LLC (1.15M shares), Soleus Capital Management, L.P. (1.13M shares), VANGUARD GROUP INC (1.01M shares), Assenagon Asset Management S.A. (411K shares), GEODE CAPITAL MANAGEMENT, LLC (402K shares), STATE STREET CORP (381K shares), ACADIAN ASSET MANAGEMENT LLC (376K shares), and RENAISSANCE TECHNOLOGIES LLC (300K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.